Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

NCT00400426 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT00400426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00400426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Lead sponsor
University of Aarhus
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
June 30, 2012
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasms, neoplasms, second primary, recurrence